Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1065353 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27738121 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27672248 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL9593894 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL1064431 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL2180897 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27705302 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL9593713 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27569510 | 0.97 | DGKA (0.41) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL28175756 | 0.97 | DGKA (0.41) | DGKATSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230046947-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2023-02-16 | — | — | US | claimed |
| EP-4069311-A1 | REACTIVE CONJUGATES | Debiopharm Research & Manufacturing SA (CH) | 2022-10-12 | — | — | EP | claimed |
| WO-2021110860-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2021-06-10 | — | — | WO | claimed |
| CN-103429269-B | Contain with the coupling of polyanion polypeptide, derived from the conjugated molecule that is used for the treatment of AIDS of the peptide of CD4 acceptor | INSTITUT PASTEUR (FR) | 2016-05-11 | — | — | CN | claimed |
| CN-103429269-A | New conjugated molecules comprising peptide derived from CD4 receptor coupled to polyanionic polypeptide for treatment of AIDS | PASTEUR INSTITUT | 2013-12-04 | — | — | CN | claimed |
| CN-103119208-A | A biocidal polyolefin yarn with 3-12 filaments | VESTERGAARD FRANDSEN SA | 2013-05-22 | — | — | CN | claimed |
| CN-101580546-A | Human anti human interferon alpha antibody and application thereof | INST OF VIRUS DISEASE CONTROL (CN) | 2009-11-18 | — | — | CN | claimed |
| CN-101168514-A | Practical synthesis method for alpha-aminosuberate and alpha-amino suberic acid monoester with optical activity | SHANGHAI PHARMATECH CO LTD (CN) | 2008-04-30 | — | — | CN | claimed |
| CN-1036832-C | Composition containing a penem or carbapenem artibiotic and the use of the same | SANKYO CO (JP) | 1997-12-31 | — | — | CN | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| CN-118369123-A | Tetrazine conjugates for in vivo targeted delivery of payloads | 坦博公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-117801204-A | Bio-based hydrolysis-resistant elastomer, preparation method and application thereof | 万华化学集团股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023150684-A2 | NANOMATERIAL AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230046947-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2023-02-16 | — | — | US | disclosed |
| CN-115279416-A | Reactive conjugates | 德彪药业国际股份公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-0408371-A1 | Hemoregulatory peptides | SMITHKLINE BEECHAM CORPORATION (US) | 1991-01-16 | — | — | EP | disclosed |
| CN-87100308-A | Polypeptide compound | — | 1987-09-16 | — | — | CN | disclosed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | disclosed |
| US-4248786-A | Hydroxy-succinimide ester compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1981-02-03 | — | — | US | disclosed |
| US-4155914-A | Hydroxy-succinimide ester compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046947-A1 | REACTIVE CONJUGATES | FCGR3B, FCGR1A, FCGR2A | DGKA 3400/4885TSHR 510/4885LMNA 4289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.